Nihon Ganka Gakkai Zasshi. 2009 Apr;113(4):492-7.

[Intravitreal tissue plasminogen activator for treatment of central retinal vein occlusion associated with diabetic retinopathy].

[Article in Japanese]

Suzuma K, Murakami T, Watanabe D, Miyamoto K, Kita M, Takagi H, Yoshimura N.

Source

Department of Ophthalmology & Visual Sciences, Graduate School of Biomedical Sciences, Nagasaki University, Japan kiyoshisuzuma@yahoo.co.jp

Abstract

PURPOSE:

To evaluate the effects of intravitreal injection of tissue plasminogen activator (tPA) on central retinal vein occlusion(CRVO) associated with diabetic retinopathy (DR).

METHODS:

A retrospective study of 42 eyes of 42 patients(mean age: 68 years, female/male = 20/22, 5 eyes associated with DR) with macular edema caused by CRVO treated with tPA. Best corrected visual acuity (BVCA or logarithm of the minimal angle of resolution: logMAR), macular thickness was mea sured by optical coherence tomography (OCT), and several variables were evaluated.

RESULTS:

The mean logMAR and macular thickness improved significantly in the DR (-) group, but, no significant changes were observed in the DR (+) group. Post-operative posterior vitreous detachment (PVD) developed in 62% of the DR (-) group and none of the DR (+) group.

CONCLUSION:

There may be no beneficial effects of intravitreal tPA on CRVO associated with diabetic retinopathy.

PMID:: 19455970; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

English Abstract

MeSH Terms

Substances

Tissue Plasminogen Activator

LinkOut - more resources

Full Text Sources

Medical Online, Meteo Inc - PDF

Medical

Supplemental Content

Save items

Related citations in PubMed

Role of posterior vitreous detachment induced by intravitreal tissue plasminogen activator in macular edema with central retinal vein occlusion. [Retina. 2007]
Role of posterior vitreous detachment induced by intravitreal tissue plasminogen activator in macular edema with central retinal vein occlusion.
Murakami T, Takagi H, Ohashi H, Kita M, Nishiwaki H, Miyamoto K, Watanabe D, Sakamoto A, Yamaike N, Yoshimura N. Retina. 2007 Oct; 27(8):1031-7.
Intravitreal triamcinolone treatment for macular edema associated with central retinal vein occlusion and hemiretinal vein occlusion. [Retina. 2005]
Intravitreal triamcinolone treatment for macular edema associated with central retinal vein occlusion and hemiretinal vein occlusion.
Cekiç O, Chang S, Tseng JJ, Barile GR, Weissman H, Del Priore LV, Schiff WM, Weiss M, Klancnik JM Jr. Retina. 2005 Oct-Nov; 25(7):846-50.
Prospective evaluation of intravitreal triamcinolone acetonide injection in macular edema associated with retinal vascular disorders. [Eur J Ophthalmol. 2005]
Prospective evaluation of intravitreal triamcinolone acetonide injection in macular edema associated with retinal vascular disorders.
Tewari HK, Sony P, Chawla R, Garg SP, Venkatesh P. Eur J Ophthalmol. 2005 Sep-Oct; 15(5):619-26.
Short-term efficacy of intravitreal bevacizumab for the treatment of macular edema due to diabetic retinopathy and retinal vein occlusion. [Int Ophthalmol. 2009]
Short-term efficacy of intravitreal bevacizumab for the treatment of macular edema due to diabetic retinopathy and retinal vein occlusion.
Astam N, Batioğlu F, Ozmert E. Int Ophthalmol. 2009 Oct; 29(5):343-8. Epub 2008 Jun 14.
Review [Etiopathogenesis in macular edema and therapeutic approach]. [Oftalmologia. 2011]
Review [Etiopathogenesis in macular edema and therapeutic approach].
Buliga S. Oftalmologia. 2011; 55(4):29-33.

See reviews... See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.

Recent activity

Clear Turn Off Turn On

[Intravitreal tissue plasminogen activator for treatment of central retinal vein...
[Intravitreal tissue plasminogen activator for treatment of central retinal vein occlusion associated with diabetic retinopathy].
Nihon Ganka Gakkai Zasshi. 2009 Apr ;113(4):492-7.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: